Stocks and InvestingStocks and Investing
Wed, October 4, 2023
Tue, October 3, 2023
Mon, October 2, 2023

Matthew Taylor Maintained (TNDM) at Strong Buy with Decreased Target to $45 on, Oct 2nd, 2023


Published on 2024-10-28 06:39:42 - WOPRAI, Matthew Taylor
  Print publication without navigation


Matthew Taylor of Jefferies, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Strong Buy with Decreased Target from $47 to $45 on, Oct 2nd, 2023.

Matthew has made no other calls on TNDM in the last 4 months.



There are 5 other peers that have a rating on TNDM. Out of the 5 peers that are also analyzing TNDM, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jeff Johnson of "Baird" Maintained at Hold with Decreased Target to $32 on, Monday, August 21st, 2023
  • Larry Biegelsen of "Wells Fargo" Maintained at Hold with Decreased Target to $30 on, Friday, August 4th, 2023


These are the ratings of the 3 analyists that currently disagree with Matthew


  • Matt Miksic of "Barclays" Maintained at Buy with Decreased Target to $62 on, Monday, August 7th, 2023
  • Joshua Jennings of "TD Cowen" Maintained at Buy with Decreased Target to $34 on, Friday, August 4th, 2023
  • Alexander Nowak of "Craig-Hallum" Maintained at Strong Buy with Decreased Target to $50 on, Tuesday, June 13th, 2023